BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 23516145)

  • 1. Immunotherapy for the management of advanced melanoma: the next steps.
    Zikich D; Schachter J; Besser MJ
    Am J Clin Dermatol; 2013 Aug; 14(4):261-72. PubMed ID: 23516145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation of immunotherapy for melanoma.
    Kirkwood JM; Tarhini AA; Panelli MC; Moschos SJ; Zarour HM; Butterfield LH; Gogas HJ
    J Clin Oncol; 2008 Jul; 26(20):3445-55. PubMed ID: 18612161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in immunotherapy for metastatic melanoma].
    Oláh J
    Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma: is immunotherapy of benefit?
    Faries MB; Morton DL
    Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of melanoma: present options and future promises.
    Rotte A; Bhandaru M; Zhou Y; McElwee KJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):115-28. PubMed ID: 25589384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination immunotherapy breakthrough for melanoma.
    Brower V
    Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
    [No Abstract]   [Full Text] [Related]  

  • 7. Gut microbiome and immunotherapy response.
    Burki TK
    Lancet Oncol; 2017 Dec; 18(12):e717. PubMed ID: 29129446
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanoma immunotherapy: historical precedents, recent successes and future prospects.
    Raaijmakers MI; Rozati S; Goldinger SM; Widmer DS; Dummer R; Levesque MP
    Immunotherapy; 2013 Feb; 5(2):169-82. PubMed ID: 23413908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.
    Shah DJ; Dronca RS
    Mayo Clin Proc; 2014 Apr; 89(4):504-19. PubMed ID: 24684873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipilimumab in advanced melanoma: reports of long-lasting responses.
    Farolfi A; Ridolfi L; Guidoboni M; Nicoletti SV; Piciucchi S; Valmorri L; Costantini M; Scarpi E; Amadori D; Ridolfi R
    Melanoma Res; 2012 Jun; 22(3):263-70. PubMed ID: 22516968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in melanoma: Recent advances and future directions.
    Franklin C; Livingstone E; Roesch A; Schilling B; Schadendorf D
    Eur J Surg Oncol; 2017 Mar; 43(3):604-611. PubMed ID: 27769635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
    Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
    G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma.
    Perier-Muzet M; Gatt E; Péron J; Falandry C; Amini-Adlé M; Thomas L; Dalle S; Boespflug A
    JAMA Dermatol; 2018 Jan; 154(1):82-87. PubMed ID: 29214290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of metastatic melanoma: an overview.
    Bhatia S; Tykodi SS; Thompson JA
    Oncology (Williston Park); 2009 May; 23(6):488-96. PubMed ID: 19544689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic melanoma - a review of current and future treatment options.
    Maverakis E; Cornelius LA; Bowen GM; Phan T; Patel FB; Fitzmaurice S; He Y; Burrall B; Duong C; Kloxin AM; Sultani H; Wilken R; Martinez SR; Patel F
    Acta Derm Venereol; 2015 May; 95(5):516-24. PubMed ID: 25520039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for melanoma.
    Bystryn JC
    Dermatol Clin; 2002 Oct; 20(4):717-25. PubMed ID: 12380059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects of immunotherapy of malignant melanoma].
    Enk A
    Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for melanoma.
    Kim CJ; Dessureault S; Gabrilovich D; Reintgen DS; Slingluff CL
    Cancer Control; 2002; 9(1):22-30. PubMed ID: 11907463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for advanced melanoma.
    Fang L; Lonsdorf AS; Hwang ST
    J Invest Dermatol; 2008 Nov; 128(11):2596-2605. PubMed ID: 18927541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.